ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Clinical trials for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE explained in plain language.

Never miss a new study

Get alerted when new ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE trials appear

Sign up with your email to follow new studies for ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1 Not yet finished but already full! 1

New hope for kids with Tough-to-Treat leukemia: experimental combo enters testing

Disease control Ongoing

This study is testing a new combination of oral drugs (selinexor and venetoclax) with standard chemotherapy for children and young adults whose acute myeloid leukemia (AML) has returned or hasn't responded to previous treatments. The main goal is to find the safest and most effec…

Matched conditions: ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Phase: PHASE1 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control

Last updated Mar 10, 2026 12:52 UTC

ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE

Get alerted when new ACUTE LEUKEMIA OF AMBIGUOUS LINEAGE IN RELAPSE trials appear

New hope for kids with Tough-to-Treat leukemia: experimental combo enters testing